14 results
algorithm asthma cardiology differential fungal guidelines pharmacology syndrome acopd apml cardiomyopathy chf chronic clinical coccidioides coccidioidomycosis cop criticalcare cryptogenic differences
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Obstructive Lung Disease ... LAMA: long-acting ... muscarinic antagonist; LABA ... #Management #Pulmonary ... #LAMA #LABA #ICS
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease Initial medical treatment of chronic obstructive pulmonary disease (COPD)
disease (COPD) ... corticosteroid; LABA ... #COPD #Treatment ... #Pulmonary #LABA ... #LAMA #SABA #SAMA
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
ICS: inhaled corticosteroids ... receptor antagonists; LABA ... immunotherapy; FEV1 ... #GINA #Asthma #Management ... #Stepwise #Pulmonary
First-line therapies for Asthma, Asthma-COPD Overlap and COPD The diagnosis of COPD, asthma, and ACO initially requires
to respiratory risk ... corticosteroids; LABA ... long-acting β2-agonist; LAMA ... #Diagnosis #Management ... Differences #Algorithm #Treatment
Chronic Obstructive Pulmonary Disease (COPD) • COPD Definition • Role of PFTs • COPD Classification and
Disease (COPD) ... post-bronchodilator FEV1 ... #Disease #COPD ... #diagnosis #management ... #GOLD2022 #treatment
Preoperative Risk Evaluation Major Pre-Op Questions: 1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... days before Pulmonary ... Determine if any labs ... medical and surgical management ... stratification #diagnosis
Pulmonary Renal Syndromes - OnePager Summary Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
life-threatening diseases ... Inflammatory eye disease ... Labs: • BMP (quantify ... #differential #diagnosis ... #management #treatment
Differentiation Syndrome in APML Epidemiology: • Incidence: common in APL (2-48% depending on the study) • Triggers:
Triggers: ATRA treatment ... Attempt if high risk ... : • Labs: leukocytosis ... Imaging: CXR- pulmonary ... #management #hematology
Peripartum Cardiomyopathy - Summary 1. Definition • Towards the end of pregnancy to 5 months postpartum
Differential Diagnosis ... Valvular heart disease ... cardiomyopathy • Pulmonary ... teratogenic GDMT meds ... #treatment
Mycoses HISTOPLASMOSIS • Inhalation of conidia → Yeast → travel to lymph nodes → spread in body • Bird
MUCORMYCOSIS • Risk ... : • Labs nonspecific ... extrapulmonary disease ... Encapsulated yeast • At risk ... #Management #Infections
No results found for "FEV1 management peds pivot diagnosis treatment pulmonary risk copd disease laba lama ics"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #FEV1 #management #peds #pivot #diagnosis #treatment #pulmonary #risk #copd #disease #laba #lama #ics